AAAAAA

   
Results: 1-24 |
Results: 24
GENETIC DETERMINATION OF PLASMA-ALDOSTERONE LEVELS IN ESSENTIAL-HYPERTENSION
Authors: POJOGA L GAUTIER S BLANC H GUYENE TT POIRIER O CAMBIEN F BENETOS A
Citation: L. Pojoga et al., GENETIC DETERMINATION OF PLASMA-ALDOSTERONE LEVELS IN ESSENTIAL-HYPERTENSION, American journal of hypertension, 11(7), 1998, pp. 856-860
REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY FOLLOWING SURGICAL-TREATMENT OF ALDOSTERONE-PRODUCING ADENOMA
Authors: MASSIEN C ABERGEL E GIRERD X MOULIN C CHATELLIER G GUYENE TT DUCLOS JM PLOUIN PF
Citation: C. Massien et al., REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY FOLLOWING SURGICAL-TREATMENT OF ALDOSTERONE-PRODUCING ADENOMA, Journal of hypertension, 16, 1998, pp. 3028-3028
DUAL NEUTRAL ENDOPEPTIDASE (NEP) ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITION IS BIOLOGICALLY DIFFERENT FROM ACE-INHIBITION, AT THE SAME LEVEL OF ACE-INHIBITION
Authors: MASSIEN C AZIZI M GUYENE TT MENARD J
Citation: C. Massien et al., DUAL NEUTRAL ENDOPEPTIDASE (NEP) ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITION IS BIOLOGICALLY DIFFERENT FROM ACE-INHIBITION, AT THE SAME LEVEL OF ACE-INHIBITION, Journal of hypertension, 16, 1998, pp. 31024-31024
PRESERVED VASODILATOR EFFECT OF BRADYKININ DESPITE BLUNTED ENDOTHELIUM-DERIVED VASODILATION IN CONSCIOUS DOGS WITH HEART-FAILURE
Authors: SU JB HOUEL R BARBE F GUYENE TT CROZATIER B HITTINGER L
Citation: Jb. Su et al., PRESERVED VASODILATOR EFFECT OF BRADYKININ DESPITE BLUNTED ENDOTHELIUM-DERIVED VASODILATION IN CONSCIOUS DOGS WITH HEART-FAILURE, Circulation, 98(17), 1998, pp. 1668-1668
PHARMACOLOGICAL DEMONSTRATION OF THE ADDITIVE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM IN SODIUM-DEPLETED HEALTHY-SUBJECTS
Authors: AZIZI M GUYENE TT CHATELLIER G MENARD J
Citation: M. Azizi et al., PHARMACOLOGICAL DEMONSTRATION OF THE ADDITIVE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM IN SODIUM-DEPLETED HEALTHY-SUBJECTS, Clinical and experimental hypertension, 19(5-6), 1997, pp. 937-951
GENETIC DETERMINATION OF PLASMA-ALDOSTERONE LEVELS
Authors: BENETOS A POIRIER O GUYENE TT GAUTIER S POJOGA L CAMBIEN F
Citation: A. Benetos et al., GENETIC DETERMINATION OF PLASMA-ALDOSTERONE LEVELS, Hypertension, 30(3), 1997, pp. 66-66
ADDITIVE EFFECTS OF LOSARTAN AND ENALAPRIL ON BLOOD-PRESSURE AND PLASMA ACTIVE RENIN
Authors: AZIZI M GUYENE TT CHATELLIER G WARGON M MENARD J
Citation: M. Azizi et al., ADDITIVE EFFECTS OF LOSARTAN AND ENALAPRIL ON BLOOD-PRESSURE AND PLASMA ACTIVE RENIN, Hypertension, 29(2), 1997, pp. 634-640
BRADYKININ PATHWAY IS INVOLVED IN ACUTE HEMODYNAMIC-EFFECTS OF ENALAPRILAT IN DOGS WITH HEART-FAILURE
Authors: BARBE F SU JB GUYENE TT CROZATIER B MENARD J HITTINGER L
Citation: F. Barbe et al., BRADYKININ PATHWAY IS INVOLVED IN ACUTE HEMODYNAMIC-EFFECTS OF ENALAPRILAT IN DOGS WITH HEART-FAILURE, American journal of physiology. Heart and circulatory physiology, 39(6), 1996, pp. 1985-1992
ACUTE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION INCREASES THE PLASMA-LEVEL OF THE NATURAL STEM-CELL REGULATOR N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE
Authors: AZIZI M ROUSSEAU A EZAN E GUYENE TT MICHELET S GROGNET JM LENFANT M CORVOL P MENARD J
Citation: M. Azizi et al., ACUTE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION INCREASES THE PLASMA-LEVEL OF THE NATURAL STEM-CELL REGULATOR N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE, The Journal of clinical investigation, 97(3), 1996, pp. 839-844
SELECTIVE RECOGNITION OF M235T ANGIOTENSINOGEN VARIANTS AND THEIR DETERMINATION IN HUMAN PLASMA BY MONOCLONAL ANTIBODY-BASED IMMUNOANALYSIS
Authors: COHEN P BADOUAILLE G GIMENEZROQUEPLO AP MANI JC GUYENE TT JEUNEMAITRE X MENARD J CORVOL P PAU B SIMON D
Citation: P. Cohen et al., SELECTIVE RECOGNITION OF M235T ANGIOTENSINOGEN VARIANTS AND THEIR DETERMINATION IN HUMAN PLASMA BY MONOCLONAL ANTIBODY-BASED IMMUNOANALYSIS, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3505-3512
THE NATURAL MUTATION Y248C OF HUMAN ANGIOTENSINOGEN LEADS TO ABNORMALGLYCOSYLATION AND ALTERED IMMUNOLOGICAL RECOGNITION OF THE PROTEIN
Authors: GIMENEZROQUEPLO AP LECONTE I COHEN P SIMON D GUYENE TT CELERIER J PAU B CORVOL P CLAUSER E JEUNEMAITRE X
Citation: Ap. Gimenezroqueplo et al., THE NATURAL MUTATION Y248C OF HUMAN ANGIOTENSINOGEN LEADS TO ABNORMALGLYCOSYLATION AND ALTERED IMMUNOLOGICAL RECOGNITION OF THE PROTEIN, The Journal of biological chemistry, 271(16), 1996, pp. 9838-9844
PRIMARY ALDOSTERONISM - DIAGNOSTIC AND PR OGNOSTIC VALUE OF POTASSIUM, RENIN, ALDOSTERONE AND THE ALDOSTERONE RENIN RATIO/
Authors: MASSIENSIMON C BATTAGLIA C CHATELLIER G GUYENE TT DUCLOS JM PLOUIN PF
Citation: C. Massiensimon et al., PRIMARY ALDOSTERONISM - DIAGNOSTIC AND PR OGNOSTIC VALUE OF POTASSIUM, RENIN, ALDOSTERONE AND THE ALDOSTERONE RENIN RATIO/, La Presse medicale, 24(27), 1995, pp. 1238-1242
DEXAMETRASONE-SENSITIVE HYPERALDOSTERONIS M WITH ADRENAL ADENOMA - CLINICAL, BIOLOGICAL AND GENETIC-ANALYSIS
Authors: JEUNEMAITRE X CHARRU A PASCOE L GUYENE TT AUPETITFAISANT B SHACKLETON CHL SCHAMBELAN M PLOUIN PF CORVOL P
Citation: X. Jeunemaitre et al., DEXAMETRASONE-SENSITIVE HYPERALDOSTERONIS M WITH ADRENAL ADENOMA - CLINICAL, BIOLOGICAL AND GENETIC-ANALYSIS, La Presse medicale, 24(27), 1995, pp. 1243-1248
RENIN ASSAYS - A DEBATE FOR CLINICIAN, NOT ONLY FOR SPECIALISTS - COMMENTARY
Authors: MENARD J GUYENE TT
Citation: J. Menard et Tt. Guyene, RENIN ASSAYS - A DEBATE FOR CLINICIAN, NOT ONLY FOR SPECIALISTS - COMMENTARY, Journal of hypertension, 13(3), 1995, pp. 367-369
RENAL AND ENDOCRINE EFFECTS OF FLOSULIDE, AFTER SINGLE AND REPEATED ADMINISTRATION TO HEALTHY-VOLUNTEERS
Authors: BRUNEL P HORNYCH A GUYENE TT SIOUFI A TURRI M MENARD J
Citation: P. Brunel et al., RENAL AND ENDOCRINE EFFECTS OF FLOSULIDE, AFTER SINGLE AND REPEATED ADMINISTRATION TO HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 49(3), 1995, pp. 193-201
CARDIOVASCULAR RISK-FACTORS AND COMBINED ESTROGEN-PROGESTIN REPLACEMENT THERAPY - A PLACEBO-CONTROLLED STUDY WITH NOMEGESTROL ACETATE AND ESTRADIOL
Authors: CONARD J DENIS C BASDEVANT A GUYENE TT THOMAS JL DEGRELLE H OCHSENBEIN E
Citation: J. Conard et al., CARDIOVASCULAR RISK-FACTORS AND COMBINED ESTROGEN-PROGESTIN REPLACEMENT THERAPY - A PLACEBO-CONTROLLED STUDY WITH NOMEGESTROL ACETATE AND ESTRADIOL, Fertility and sterility, 64(5), 1995, pp. 957-962
ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITIONAND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES
Authors: AZIZI M CHATELLIER G GUYENE TT MURIETAGEOFFROY D MENARD J
Citation: M. Azizi et al., ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITIONAND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES, Circulation, 92(4), 1995, pp. 825-834
DOSE-DEPENDENT EFFECTS OF THE RENIN INHIBITOR ZANKIREN HCL AFTER A SINGLE ORAL DOSE IN MILDLY SODIUM-DEPLETED NORMOTENSIVE SUBJECTS
Authors: MENARD J BOGER RS MOYSE DM GUYENE TT GLASSMAN HN KLEINERT HD
Citation: J. Menard et al., DOSE-DEPENDENT EFFECTS OF THE RENIN INHIBITOR ZANKIREN HCL AFTER A SINGLE ORAL DOSE IN MILDLY SODIUM-DEPLETED NORMOTENSIVE SUBJECTS, Circulation, 91(2), 1995, pp. 330-338
ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM HAS NO INFLUENCE ON THE CIRCULATING RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM OR BLOOD-PRESSURE IN NORMOTENSIVE SUBJECTS
Authors: LACHURIE ML AZIZI M GUYENE TT ALHENCGELAS F MENARD J
Citation: Ml. Lachurie et al., ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM HAS NO INFLUENCE ON THE CIRCULATING RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM OR BLOOD-PRESSURE IN NORMOTENSIVE SUBJECTS, Circulation, 91(12), 1995, pp. 2933-2942
BLOOD-PRESSURE EFFECTS OF ACUTE INTRAVENOUS RENIN OR ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ESSENTIAL-HYPERTENSION
Authors: AZIZI M GUYENE TT CHATELLIER G MENARD J
Citation: M. Azizi et al., BLOOD-PRESSURE EFFECTS OF ACUTE INTRAVENOUS RENIN OR ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ESSENTIAL-HYPERTENSION, Journal of hypertension, 12(4), 1994, pp. 419-427
RELATIONSHIPS BETWEEN ANGIOTENSIN-I CONVERTING-ENZYME GENE POLYMORPHISM, PLASMA-LEVELS, AND DIABETIC RETINAL AND RENAL COMPLICATIONS
Authors: MARRE M BERNADET P GALLOIS Y SAVAGNER F GUYENE TT HALLAB M CAMBIEN F PASSA P ALHENCGELAS F
Citation: M. Marre et al., RELATIONSHIPS BETWEEN ANGIOTENSIN-I CONVERTING-ENZYME GENE POLYMORPHISM, PLASMA-LEVELS, AND DIABETIC RETINAL AND RENAL COMPLICATIONS, Diabetes, 43(3), 1994, pp. 384-388
CYCLOSPORINE-INDUCED STIMULATION OF THE RENIN-ANGIOTENSIN SYSTEM AFTER LIVER AND HEART-TRANSPLANTATION
Authors: JULIEN J FARGE D KREFTJAIS C GUYENE TT PLOUIN PF HOUSSIN D CARPENTIER A CORVOL P
Citation: J. Julien et al., CYCLOSPORINE-INDUCED STIMULATION OF THE RENIN-ANGIOTENSIN SYSTEM AFTER LIVER AND HEART-TRANSPLANTATION, Transplantation, 56(4), 1993, pp. 885-891
HEMOSTATIC AND METABOLIC EFFECTS OF LOWERING THE ETHINYL-ESTRADIOL DOSE FROM 30 MCG TO 20 MCG IN ORAL-CONTRACEPTIVES CONTAINING DESOGESTREL
Authors: BASDEVANT A CONARD J PELISSIER C GUYENE TT LAPOUSTERLE C MAYER M GUYGRAND B DEGRELLE H
Citation: A. Basdevant et al., HEMOSTATIC AND METABOLIC EFFECTS OF LOWERING THE ETHINYL-ESTRADIOL DOSE FROM 30 MCG TO 20 MCG IN ORAL-CONTRACEPTIVES CONTAINING DESOGESTREL, Contraception, 48(3), 1993, pp. 193-204
INHIBITION OF BRADYKININ DEGRADATION PARTICIPATES TO THE HEMODYNAMIC-EFFECTS OF ENALAPRILAT IN CONSCIOUS DOGS WITH HEART-FAILURE
Authors: BARBE F SU JB GUYENE TT CROZATIER B MENARD J HITTINGER L
Citation: F. Barbe et al., INHIBITION OF BRADYKININ DEGRADATION PARTICIPATES TO THE HEMODYNAMIC-EFFECTS OF ENALAPRILAT IN CONSCIOUS DOGS WITH HEART-FAILURE, Circulation, 88(4), 1993, pp. 91-91
Risultati: 1-24 |